In a recent study, Dr. Beth Scaffidi analyzed the images of a unique trophy head from southern Peru. The study diagnosed the ...

An international research team involving the German Primate Center—Leibniz Institute for Primate Research (DPZ), Hannover ...

Dr. Michael Heide Phone: +49 551-3851-323 Email: [email protected] Dr. Indra Niehaus Phone: + 49 511 532-82747 Email:[email protected] ...

As previously reported, Craig-Hallum analyst Albert Lowe initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $175 price ...

We made three attempts to capture a jaguar after arriving at Fazenda Bodoquena in Miranda, Mato Grosso do Sul state, on a ...

BTIG initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $167 price target Palvella is a clinical stage biopharmaceutical ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...

A Cork dad says his family are going through a "living nightmare" as his 3-month-old will soon undergo her third procedure for her life-threatening brain condition.

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...

Good morning, everyone, and welcome to Ligand's 2025 Investor Day. I'm Melanie Herman, Head of Investor Relations for Ligand. And on behalf of our entire team, I'd like to thank you for taking the ...

UCB, a global biopharmaceutical company, today announced it will present 21 abstracts at the American Epilepsy Society (AES) Annual Meeting (December 5-9, 2025). Data include primary efficacy and ...

A series where we find out which products the professionals (who really know what they’re talking about) actually use and really stand behind. Read more here. Maybe you’ve seen an influencer gliding ...